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Purpose: Readmission and mortality rates of patients with heart failure are good indicators of care quality. To determine whether 
hospital resources are associated with care quality for cardiac patients, we analyzed the effect of number of physicians and the 
combined effects of number of physicians and beds on 30-day readmission and 1-year mortality. 
Materials and Methods: We used national cohort sample data of the National Health Insurance Service (NHIS) claims in 2002−2013. 
Subjects comprised 2345 inpatients (age: >65 years) admitted to acute-care hospitals for heart failure. A multivariate Cox regres-
sion was used. 
Results: Of the 2345 patients hospitalized with heart failure, 812 inpatients (34.6%) were readmitted within 30 days and 190 (8.1%) 
had died within a year. Heart-failure patients treated at hospitals with low physician volumes had higher readmission and mortality 
rates than high physician volumes [30-day readmission: hazard ratio (HR)=1.291, 95% confidence interval (CI)=1.020−1.633; 
1-year mortality: HR=2.168, 95% CI=1.415−3.321]. Patients admitted to hospitals with low or middle bed and physician volume 
had higher 30-day readmission and 1-year mortality rates than those admitted to hospitals with high volume (30-day readmis-
sion: HR=2.812, 95% CI=1.561−5.066 for middle-volume beds & low-volume physicians, 1-year mortality: HR=8.638, 95% 
CI=2.072−36.02 for middle-volume beds & low-volume physicians).
Conclusion: Physician volume is related to lower readmission and mortality for heart failure. Of interest, 30-day readmission and 
1-year mortality were significantly associated with the combined effects of physician and institution bed volume.
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INTRODUCTION
Quality assessment, based on readmission and mortality rate 
of inpatients, in teaching hospitals and hospitals with 500 or 
more beds has been initiated by Health Insurance Review and 
Assessment service of Korea (HIRA) since 2015 expecting to 
reduce unnecessary admission. Since 2009, penalties or in-
centives have been applied in the Unites States to hospitals ac-
cording to the ‘Assessment criteria for readmission rate.’ The 
indices of healthcare quality assessment in Korea include 5 
areas; patient safety and healthcare quality, public function, 
healthcare delivery system, education, and research. In HIRA’s 
new amendment, more patient safety and healthcare quality’ 
area are emphasized, showing highest and moreover in-
creased weight (from 60% to 65%). This revision represents the 
Korean governmental side of view on the importance of patient 
safety and healthcare quality area, especially emphasized the 
number of doctors per inpatient. On the other hand, the exe-
cution plan has encountered strong criticism of medical spe-
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cialists, who suggested that the policy is one sided and hasn’t 
reflected their opinions. Thus, there remain so far conflicting 
views on quality assessment for readmission and mortality 
rate. Globally, heart failure is the leading cause of readmission 
and death in individuals over 65 years of age.1-3 The preva-
lence of heart failure in South Korea rose from 94421 in 2009 to 
115063 in 2013, an increase of 4.5% per 100000, and treatment 
cost increased from 718 hundred million won in 2009 to 963 
hundred million in 2013, a 1.3-fold increase.4 Despite its impor-
tance, however, few epidemiological studies have been carried 
out to examine readmission and mortality for heart failure in 
Korea.5 Nevertheless, a Korean Acute Heart Failure Registry 
study found a 90-day readmission rate of 7.1% and 1-year mor-
tality rate of 15%.6 
Readmission can be avoidable, and financial and social bur-
dens of 30-day readmissions are enormous.7 A 2009 meta-anal-
ysis found that urgent readmissions are often preventable and 
the most common investigation period was 30 days post-dis-
charge.8 Since readmission involves unnecessary medical costs, 
the reduction of avoidable readmission appears to be urgently 
needed to improve the quality of healthcare.9
Physician volume may significantly affect outcomes of care 
for heart-failure patients.10 Although heart-failure patients’ re-
admission is an important national concern, most previous 
studies have focused on surgeon volume and surgical care out-
comes.11-13 Only a limited number of studies have investigated 
the relationship between physician volume and heart-failure 
outcomes (readmission and mortality) with nationwide data. 
An indirect evidence suggests that physician volume influences 
heart failure outcomes: hospitals with greater capacity as well 
as high physician volume are more likely to have better out-
comes. However, these two indexes are distinct; the relation-
ship between the number of hospital beds and health out-
comes may differ from the relationship between physician 
volume and health outcomes. Better health outcomes in hos-
pitals with a greater capacity may reflect a superior system.
Thus, we attempted to verify the effect of physician volume 
on health outcomes in heart-failure patients (30-day readmis-
sion and 1-year mortality) and the combined effects of num-
ber of physicians and beds, using nationwide cohort data from 
2003 to 2013. Because the financial and social burden of heart-
failure readmission and mortality is of national concern, it is 
necessary to examine hospital-related determinants to improve 
the quality of care through institutional intervention. 
MATERIALS AND METHODS
Data source and study sample
This study used nationwide cohort sample data of National He-
alth Insurance Service (NHIS) claims in 2003−2013. NHIS is 
obligatory and covers the entire Korean population. Cohort 
NHIS sample data include approximately one million patients 
as representative of the Korean population. Data of randomly 
sampled individuals were classified according to gender, age, 
income level, region, and individual medical costs at the base-
line and follow-ups until 2013. Data included subjects’ demo-
graphics (gender, age, income level, and region) and medical 
care history [International Classification of Disease (ICD-10) 
diagnoses, medical treatment, and health examination], and 
hospital characteristics (ownership, number of beds, and num-
ber of doctors). In addition, numbers were assigned for pa-
tients’ mortality data from the Korea National Statistical Office 
to maintain confidentiality.
We selected patients over 65 years of age who had been ad-
mitted to acute-care hospitals for heart failure in 2003–2013. 
For inclusion, subjects had to be over 65 years of age with a pri-
mary diagnosis of heart failure, identified by ICD-10 code I50.x. 
This is because older patients with heart failure differ from 
younger patients. We excluded patients in clinics/physician of-
fices and long-term-care hospitals for homogeneity. We, there-
fore, identified 1392 heart-failure patients who met these criteria.
Outcome measures
Outcome variables were 30-day readmission and 1-year mor-
tality for heart failure as readmission and mortality, respec-
tively.14,15 In this study, 30-day readmission was defined as re-
admission for any cause within 30-days post-discharge at the 
hospital where the individual received treatment for heart fail-
ure. In the current study, we analyzed the readmission as re-
peated event. Discharge and readmission information was 
obtained from medical records. Finally, 1-year mortality was 
defined as death by any cause within a year after the admis-
sion date for heart failure. The observation period for mortality 
was longer than one year.
Covariates
The main independent variable was the number of physicians 
in acute-care hospitals. This study grouped the number of phy-
sicians into tertile. For the combined effect analysis, physician 
volume was classified as low (≤16), medium (17−165), and high 
(>165). Bed volume was also divided into three categories: 
low (≤500), medium (501−1000), and high (>1000). Individual 
variables included demographics (gender, age, income level), 
admission pathway, and comorbidity [Charlson comorbidity 
index (CCI) which was calculated with all the medical records 
of comorbidities in 2002−2013, acute myocardial infarction 
(AMI), vascular or circulatory disease, chronic obstructive pul-
monary disease (COPD), pneumonia, and diabetes]. Institu-
tional variables included hospital ownership (public or pri-
vate), number of beds, and number of physicians. 
Statistical analysis
Categorical variables were expressed as frequencies and per-
centages, and continuous variables were described as means 
and standard deviations. Chi-square tests and t-tests were used 
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to assess differences in characteristics according to readmis-
sion and mortality rates. Kaplan-Meier survival curves were 
constructed for physician volume (high, medium, and low), 
and comparisons were made using log-rank tests. We used Cox 
proportional hazard models using a shared-frailty model. SAS 
9.4 software (SAS Institute Inc., Cary, NC, USA) was used for all 
analyses. 
RESULTS
The analysis of the sample’s characteristics by 30-day readmis-
sion and 1-year mortality are shown in Table 1. Of the 2345 
subjects (patients hospitalized with heart failure in 2002−2013), 
812 (34.6%) were readmitted within 30 days and 190 (8.1%) 
died within one year. High physician volume was lower for 
those who were readmitted within 30 days or died within one 
year than those who were not readmitted or had survived lon-
ger than a year. A significantly greater number of patients with 
high CCI scores had a greater likelihood of 30-day readmis-
sion than those with low CCI scores. Patients readmitted within 
30 days had a higher likelihood of AMI, vascular or circulatory 
disease, COPD, pneumonia, and diabetes than those who were 
not readmitted. Patients who were readmitted within 30 days 
or who died within one year were more likely to have been ad-
mitted to hospitals with fewer beds than those with greater ca-
pacity. The proportions of 30-day readmission and 1-year mor-
tality by year are shown in Supplementary Fig. 1 (only online).
According to the Cox proportional hazard models, physician 
volume was significantly associated with 30-day readmission 
and 1-year mortality [30-day readmission: hazard ratio (HR)= 
1.291, 95% confidence interval (CI)=1.020−1.633 for low num-
ber of doctors, HR=1.809, 95% CI=1.459−2.242 for middle num-
ber of doctors; 1-year mortality: HR=2.168, 95% CI=1.415−3.321 
for low number of doctors, HR=1.816, 95% CI=1.187−2.777 for 
middle number of doctors] (Table 2). Patients who were ad-
mitted in hospitals with low bed volume were more likely to be 
readmitted within 30 days (HR=1.430, 95% CI=1.068−1.915), 
and die within 1-year (HR=2.246, CI=1.304−3.868).
Patients admitted to hospitals with high bed and physician 
volume had low 30-day readmission and 1-year mortality rates 
than those admitted to hospitals with low or middle volume 
(Fig. 1).
Fig. 2 shows the results of a multivariate Cox proportional 
hazard model for the combined effects of number of physi-
cians and beds on 30-day readmission and 1-year mortality. 
Patients admitted in hospitals with higher numbers of physi-
cians and beds were less likely to be readmitted within 30 days 
or die within 1-year after discharge. Similarly, the likelihood 
of 30-day readmission and 1-year mortality was lower in hospi-
tals with high physician volumes and low capacity. Generally, 
30-day readmission and 1-year mortality were negatively re-
lated to both the numbers of physicians and beds together. 
This study found significant effects of physician and bed vol-
ume on readmission and mortality: in hospitals with low or 
middle physician and bed volume, both 30-day readmission 
and 1-year mortality were higher than in hospitals with high 
numbers of physicians and beds (30-day readmission: HR= 
2.812, 95% CI=1.561−5.066 for middle-volume beds & low-
volume physicians, HR=3.781, 95% CI=2.119−6.746 for mid-
dle-volume beds & middle-volume physicians; 1-year mortal-
ity: HR=8.638, 95% CI=2.072−36.02 for middle-volume beds & 
low-volume physicians, HR=6.156, 95% CI=1.488−26.176 for 
middle-volume beds & middle-volume physicians).
DISCUSSION
Despite advanced and reliable healthcare service quality in 
South Korea, the imbalance between human and material re-
sources remains as a problem to be solved. The number of hos-
pital beds in Korea has been doubled during 2004−2013 while 
OECD average increase was only 10%. On the other hand, the 
number of medical doctors per 1000 populations remains the 
lowest among the OECD members average, 2.2 vs. 3.3.16 This 
imbalance may lead to adverse effect of healthcare quality in-
cluding readmission and mortality. 
We, therefore, examined whether physician volume was as-
sociated with cardiac-related readmission and mortality, as 
they are considered good indicators of quality of care. Of the 
2345 elderly patients with heart failure admitted to acute-care 
hospitals, 34.6% were readmitted within 30 days and 8.1% 
died within a year of the initial hospitalization. The 30-day re-
admission rate for heart failure in the United States (US) was 
21.3% in 2003−2006,17 and 24.8% in 2007−2009.18 Moreover, the 
30-day mortality rate was 11.2% in 2005−2008.19 In Russia, the 
60-day readmission rate was 6.4%, and the 60-day mortality 
rate was 8.1%, whereas, the corresponding values in Eastern 
Europe were 19.4% and 9.9%.20 Heart-failure readmission and 
mortality rates in South Korea have been shown to be high in 
comparison to other countries. However, the study population, 
outcomes, and inclusion criteria in the present study are dif-
ferent from those in these studies. 
In the present study, elderly patients with heart failure who 
were treated at acute-care hospitals with low physician vol-
umes were more likely to be readmitted within 30 days or die 
within a year. Moreover, the combined effects of number of 
physicians and beds on 30-day readmission and 1-year mor-
tality were significant: in general, patients admitted in hospi-
tals with low or middle number of physicians and beds were 
more likely to be readmitted within 30 days or die within 
1-year after discharge compared to those in hospitals with high 
physician and bed volumes. However, the condition of patients 
admitted in hospitals with low physician volume and low ca-
pacity might less severe than those with high volume and high 
capacity. Patients admitted in hospitals with miidlephysician 
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Table 1. Characteristics according to 30-day Readmission and 1-year Mortality among Inpatients with Heart Failure in 2002–2013 
30-day readmission 1-year mortality
No, n (%) Yes, n (%) p value No, n (%) Yes, n (%) p value
Individual level
Sex   
Men 508 (63.3) 294 (36.7)
0.1485
732 (91.3) 70 (8.7)
0.471
Women 1025 (66.4) 518 (33.6) 1423 (92.2) 120 (7.8)
Age
65−69 181 (67.3) 88 (32.7)
0.6888
258 (95.9) 11 (4.1)
0.014
70−74 289 (63.9) 163 (36.1) 421 (93.4) 30 (6.7)
75−79 371 (65.6) 195 (34.5) 520 (92.2) 44 (7.8)
80−84 346 (63.7) 197 (36.3) 496 (90.8) 50 (9.2)
≥85 346 (67.2) 169 (32.8) 460 (89.3)    55 (10.7)
Income
Medical aid 113 (62.8) 67 (37.2)
0.0827
169 (93.9) 11 (6.1)
0.032
Low 442 (69.4) 195 (30.6) 599 (94.2) 37 (5.8)
Middle 433 (64.8) 235 (35.2) 603 (90.1) 66 (9.9)
High 545 (63.4) 315 (36.6) 784 (91.2) 76 (8.8)
Pathway
Outpatient 660 (63.8) 374 (36.2)
0.1766
1224 (93.7) 83 (6.4)
0.001
Emergency 873 (66.6) 438 (33.4) 931 (89.7) 107 (10.3)
CCI
0 700 (71.5) 279 (28.5)
<0.0001
890 (90.9) 89 (9.1)
0.063
1 349 (64.6) 191 (35.4) 493 (91.3) 47 (8.7)
2 233 (63.0) 137 (37.0) 339 (91.6) 31 (8.4)
≥3 251 (55.0) 205 (45.0) 433 (95.0) 23 (5.0)
AMI
No 1398 (66.1) 717 (33.9)
0.0301
1947 (92.1) 168 (7.9)
0.466
Yes 135 (58.7) 95 (41.3) 208 (90.4) 22 (9.6)
Vascular or circulatory  
  disease
No 1286 (66.9) 637 (33.1)
0.0013
1767 (91.9) 156 (8.1)
0.970
Yes 247 (58.5) 175 (41.5) 388 (91.9) 34 (8.1)
COPD
No 1431 (66.3) 729 (33.8)
0.003
1984 (91.9) 176 (8.2)
0.891
Yes 102 (55.1) 83 (44.9) 171 (92.4) 14 (7.6)
Pneumonia
No 1234 (67.6) 592 (32.4)
<0.0001
1676 (91.8) 150 (8.2)
0.777
Yes 299 (57.6) 220 (42.4) 479 (92.3) 40 (7.7)
Diabetes
No 1378 (66.4) 698 (33.6)
0.0056
1906 (91.8) 170 (8.2)
0.758
Yes 155 (57.6) 114 (42.4) 249 (92.6) 20 (7.4)
β blocker
No 756 (66.3) 385 (33.7)
0.4048
1031 (90.4) 110 (9.6)
0.010
Yes 777 (64.5) 427 (35.5) 1124 (93.4) 80 (6.6)
ACE inhibitors
No 721 (65.2) 385 (34.8)
0.8944
1023 (92.5) 83 (7.5)
0.354
Yes 812 (65.5) 427 (34.5) 1132 (91.4) 107 (8.6)
Diuretics
No 194 (68.6) 89 (31.5)
0.2577
264 (93.3) 19 (6.7)
0.426
Yes 1339 (64.9) 723 (35.1) 1891 (91.7) 171 (8.3)
Aldosterone antagonists
No 634 (65.9) 328 (34.1)
0.6841
891 (92.6) 71 (7.4)
0.321
Yes 899 (65.0) 484 (35.0) 1264 (91.4) 119 (8.6)
Angiotensin receptor  
  blockers
No 537 (68.1) 252 (31.9)
0.0572
715 (90.6) 74 (9.4)
0.125
Yes 996 (64.0) 560 (36.0) 1440 (92.5) 116 (7.5)
Isosorbide dinitrate and  
  hydralazine
No 1119 (66.1) 574 (33.9)
0.2557
1557 (92.0) 136 (8.0)
0.910
Yes 414 (63.5) 238 (36.5) 598 (91.7) 54 (8.3)
Digoxin
No 784 (65.9) 406 (34.1)
0.6293
1109 (93.2) 81 (6.8)
0.024
Yes 749 (64.9) 406 (35.2) 1046 (90.6) 109 (9.4)
Hospital classification
Teaching hospital or  
  general hospital
1248 (65.5) 657 (34.5)
0.8118
1752 (92.0) 153 (8.0)
0.869
Hospital 285 (64.8) 155 (35.2) 403 (91.6) 37 (8.4)
Ownership
Public 126 (72.4) 48 (27.6)
0.0517
158 (90.3) 17 (9.7)
0.504
Private 1407 (64.8) 764 (35.2) 1997 (92.0) 173 (8.0)
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and bed volumes were more likely to be readmitted within 30 
days or die within 1-year than those patients admitted in hos-
pitals with low number of physicians.
Consistent with previous studies,21,22 the present findings 
show that patients admitted in hospitals with a high physician 
volume had a significantly lower risk of readmission and death 
than those admitted in hospitals with low physician volume. 
A previous study has found that higher physician volume is 
associated with lower risk of mortality for heart failure.10 Fur-
thermore, studies on combined effects showed that high phy-
sician volume and hospital-bed ratio has better outcomes 
(post-surgery mortality).23,24 However, some studies found that 
high physician volume is not significantly associated with mor-
tality and even found a positive relationship to readmission.13,25 
The present study has several limitations. Readmission and 
mortality rates could be underestimated since this study in-
Table 1. Characteristics according to 30-day Readmission and 1-year Mortality among Inpatients with Heart Failure in 2002–2013 
30-day readmission 1-year mortality
No, n (%) Yes, n (%) p value No, n (%) Yes, n (%) p value
Number of beds
−500 648 (65.3) 345 (34.7)
0.6466
903 (91.1) 88 (8.9)
0.057501−1000 538 (64.7) 294 (35.3) 761 (91.3) 73 (8.8)
1001− 347 (66.7) 173 (33.3) 491 (94.4) 29 (5.6)
Number of doctors
Low 480 (62.9) 283 (37.1)
<0.0001
687 (89.9) 77 (10.1)
0.003Middle 367 (53.1) 324 (46.9)  628 (91.0) 62 (9.0)
High 686 (77.0) 205 (23.0) 840 (94.3) 51 (5.7)
Combined variable
Low-volume beds &  
  low-volume physicians
124 (72.1) 48 (27.9)
<0.0001
161 (93.6) 11 (6.4)
<0.0001
Low-volume beds & 
  middle-volume physicians
176 (52.5) 159 (47.5) 298 (89.5) 35 (10.5)
Low-volume beds & 
  high-volume physicians
348 (71.6) 138 (28.4) 444 (91.4) 42 (8.6)
Middle-volume beds & 
  low-volume physicians
201 (63.0) 118 (37.0) 279 (87.2) 41 (12.8)
Middle-volume beds & 
  middle-volume physicians
132 (49.4) 135 (50.6) 243 (90.7) 25 (9.3)
Middle-volume beds & 
  high-volume physicians
205 (83.3) 41 (16.7) 239 (97.2) 7 (2.9)
High-volume beds & 
  low-volume physicians
155 (57.0) 117 (43.0) 247 (90.8) 25 (9.2)
High-volume beds & 
  middle-volume physicians
59 (66.3) 30 (33.7) 87 (97.8) 2 (2.3)
High-volume beds & 
  high-volume physicians
133 (83.7) 26 (16.4)  157 (98.7) 2 (1.3)
Hospital level
Hospital classification
Teaching hospital or  
  general hospital
107 (32.4) 223 (67.6)
<0.0001
229 (69.4) 101 (30.6)
<0.0001
Hospital 283 (66.0) 146 (34.0) 394 (91.8) 35 (8.2)
Ownership
Public 16 (37.2) 27 (62.8)
0.0788
29 (67.4) 14 (32.6)
0.018
Private 374 (52.2) 342 (47.8) 594 (83.0) 122 (17.0)
Number of beds
−500 367 (59.3) 252 (40.7)
<0.0001
545 (88.1) 74 (12.0)
<0.0001 501−1000 22 (19.8) 89 (80.2) 62 (55.9) 49 (44.1)
 1001− 1 (3.5) 28 (96.6) 16 (55.2) 13 (44.8)
Number of doctors
Low 207 (62.5) 124 (37.5)
<0.0001
165 (79.7) 42 (20.3)
0.004Middle 77 (33.3) 154 (66.7) 167 (76.6) 51 (23.4)
High 106 (53.8) 91 (46.2) 291 (87.1) 43 (12.9)
Total (individual level) 1533 (65.4) 812 (34.6) 2155 (91.9) 190 (8.1)
Total (hospital level) 390 (51.4) 369 (48.6) 623 (82.1) 136 (17.9)
SD, standard deviation; CCI, charlson comorbidity index; AMI, acute myocardial infarction; COPD, chronic obstructive pulmonary disease; ACE, angiotensin con-
verting enzyme.
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Table 2. Multivariate Cox Proportional Hazard Models with 30-day Readmission and 1-year Mortality in 2002−2013
Individual level
30-day all-cause readmission 1-year mortality
HR 95% CI HR 95% CI
Sex
Men 1.000 1.000
Women 1.067 0.889–1.281 0.816 0.587–1.136
Age
65−69 1.000 1.000
70−74 1.209 0.888–1.648 1.656 0.771–3.558
75−79 0.981 0.721–1.333 1.993 0.955–4.157
80−84 0.873 0.634–1.200 2.084 0.995–4.367
≥85 1.020 0.737–1.411 2.884 1.384–6.011
Income
Medical aid 1.081 0.775–1.508 0.559 0.264–1.184
Low 0.907 0.729–1.130 0.779 0.509–1.191
Middle 1.050 0.853–1.291 1.154 0.797–1.670
High 1.000 1.000
Pathway
Outpatient 1.000 1.000
Emergency 1.225 1.029–1.459 1.974 1.418–2.747
CCI
0 1.000 1.000
1 0.848 0.664–1.083 0.737 0.487–1.116
2 0.929 0.714–1.208 0.601 0.368–0.981
≥3 0.956 0.746–1.224 0.225 0.121–0.418
AMI
No 1.000 1.000
Yes 0.955 0.728–1.252 1.574 0.931–2.662
Vascular or circulatory disease
No 1.000 1.000
Yes 1.034 0.846–1.265 0.852 0.558–1.301
COPD
No 1.000 1.000
Yes 1.134 0.860–1.495 1.109 0.598–2.057
Pneumonia
No 1.000 1.000
Yes 1.101 0.913–1.327 0.708 0.471–1.064
Diabetes
No 1.000 1.000
Yes 0.888 0.690–1.143 1.193 0.679–2.095
β blocker
No 1.000 1.000
Yes 1.104 0.921–1.324 1.308 0.929–1.841
ACE inhibitors
No 1.000 1.000
Yes 0.983 0.825–1.173 0.590 0.423–0.823
Diuretics
No 1.000 1.000
Yes 1.610 1.079–2.401 1.356 0.738–2.491
Aldosterone antagonists
No 1.000 1.000
Yes 1.030 0.842–1.261 0.844 0.582–1.224
Angiotensin receptor blockers
No 1.000 1.000
Yes 0.981 0.802–1.201 0.660 0.467–0.933
Isosorbide dinitrate and hydralazine
No 1.000 1.000
Yes 1.052 0.873–1.268 1.021 0.712–1.464
Digoxin
No 1.000 1.000
Yes 1.165 0.970–1.399 1.531 1.079–2.174
Ownership
Public 1.000 1.000
Private 1.067 0.765–1.488 0.843 0.478–1.488
Number of beds
−500 1.430 1.068–1.915 2.246 1.304–3.868
 501−1000 1.374 1.064–1.773 1.801 1.123–2.886
 1001− 1.000 1.000
Number of doctors
Low 1.291 1.020–1.633 2.168 1.415–3.321
Middle 1.809 1.459–2.242 1.816 1.187–2.777
High 1.000 1.000
HR, hazard ratio; CCI, charlson comorbidity index; AMI, acute myocardial infarction; COPD, chronic obstructive pulmonary disease; ACE, angiotensin converting 
enzyme.
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cluded only patients with heart failure admitted in acute-care 
hospitals. Furthermore, since only patients over 65 years of age 
were included in this study, the results cannot be extended to 
patients 65 years or younger. We were unable to account for 
severity of heart failure, reasons for readmission, and cause of 
death, as the NHIS data did not include these informations. 
Inaccuracy of risk adjustment may lead to skewed results be-
cause severe cases of heart failure tend to be concentrated in 
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large hospitals with a large number of physicians. Therefore, 
we controlled for admission pathway, CCI scores, and several 
diseases related to heart failure. Moreover, since the sample 
data were limited in scope, we were unable to consider all pos-
sible covariates associated with readmission and mortality for 
heart failure, as well as physician specialization. While this study 
examined the effects, the results do not prove the causality. 
Since NHI data has limitation for accuracy of diagnosis, we 
recommend that the results be interpreted with care. 
Despite these limitations, the current study has several st-
rengths. Using national data of one million patients and strati-
fied random sampling ensured external validity and permit-
ted transnational comparisons. To the best of our knowledge, 
this is the first study to examine the effects of physician volume 
on heart-failure patients’ readmission and mortality in Korea. 
Furthermore, since this is an empirical cohort study, the asso-
ciation observed between physician volume and readmission 
and mortality has greater support than a cross-sectional de-
sign would allow. We controlled patients (demographic, so-
cioeconomic, and medical factors) and institutional factors, as 
they affect readmission and ultimately patient outcomes. Most 
previous studies on readmission did not consider patients’ de-
mographics or hospital-related factors. Furthermore, this study 
used medical-history and mortality data from NHIS claims 
and reliable national statistics. We attempted to homogenize 
the study population by using clear inclusion criteria: patients 
over 65 years of age who were admitted to acute-care hospi-
tals for heart failure. Finally, the present findings are useful to 
policy makers who develop strategies to control hospital read-
mission rates and mortality. This ultimately helps improve the 
quality of care for heart failure, which is of national importance. 
Thus, consideration of physician volumes in hospitals when 
formulating and implementing various health policies is nec-
essary.
In conclusion, hospital physician volumes were inversely 
related to readmission and mortality in patients with heart 
failure. Furthermore, the combined effect of number of beds 
and physicians on readmission and mortality was significant. 
Therefore, hospital capacity might be a modifier of physician 
volumes’ effect on readmission and mortality, especially in 
acute-care hospitals with fewer beds. Thus, the present find-
ings provide evidence for developing new strategies to reduce 
avoidable readmission and mortality. Policy makers should 
continue to monitor readmission and mortality rates for heart 
failure and identify hospitals with low physician volumes to en-
sure good quality care, especially in those with a smaller capacity.
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